Weiss, Norbert http://orcid.org/0000-0002-0040-1109
Zamponi, Gerald W. http://orcid.org/0000-0002-0644-9066
Funding for this research was provided by:
Grantová Agentura České Republiky (22-23242S)
National Institute for Research of Metabolic and Cardiovascular Diseases (LX22NPO5104)
Article History
Received: 26 September 2022
Revised: 29 September 2022
Accepted: 1 October 2022
First Online: 5 October 2022
Declarations
:
: G.W.Z. is Chief Scientific Officer of Zymedine Therapeutics.
: N.W. has no competing interests to declare. G.W.Z. is Chief Scientific Officer of Zymedine Therapeutics.